The following letter was written by Dr. Amy Brooks-Kayal to a state representative in Pennsylvania. Here is an article where the letter had been published.
March 22, 2015
As Pennsylvania considers enacting new cannabis legislation (HB 193), I write to offer the perspective of the American Epilepsy Society (AES), the leading U.S. organization of clinical and research professionals specializing in the treatment and care of people with epilepsy. Continue reading American Epilepsy Association Statement on CBD Oils
CNN’s Dr. Sanjay Gupta left the wrong impression on many Americans when discussing marijuana, which is why the media needs to stop saying medical marijuana when they mean cannabidiol or CBD. Marijuana is very different from cannabidiol, the marijuana derivative which Dr. Gupta advocates for treating some types of epilepsy in children.
The marijuana plant has more than 400 compounds, and at least 60 different cannabinoids which bind to receptors in our body. Cannabidiol is one of those 60 cannabinoids. Tetrahydrocannabinol or THC is a different cannabinoid, the main psychoactive component and the one responsible for the “high” of marijuana.
The medical marijuana advocates have intentionally confused the public about medical marijuana research at this time. Cannabidiol has been isolated by a company in Great Britain and is being fast-tracked for approval by the Food and Drug Administration (FDA). Continue reading Explaining Cannabidiol or CBD